Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian.

Gene - 20 Jan 2023

Guo Le, Zhang Wenjie, Meng Wenting, Zhao Weiwei, Hao Jie, Hu Xiuxia, Jin Tianbo

Abstract excerpt

PURPOSE: Our study genotyped pharmacogenes in 200 individuals from Inner Mongolia Autonomous Region, China. Aim to find distinct pharmacogenomic variations among the Mongolian population and to investigate the potential clinically operable gene-drug connection and genotype-phenotype correlation of differential variation in the Mongolian population. METHODS: We sampled 61 variations of 28 genes in PharmGKB and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Inflammatory Agents
Share to Arachidonate 5-Lipoxygenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arylamine N-Acetyltransferase

Share to Asian People

Share to Cyclooxygenase 2

Share to Cytochrome P-450 CYP2D6

Share to Pharmacogenomic Variants

Source

Identifiers

PMID: 36220448
DOI: 10.1016/j.gene.2022.146960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Very important pharmacogenes polymorphism landscape and potential clinical relevance in the Chinese Mongolian.PMID 36220448Read ↗

The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.Semantic proximity Read ↗

Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.Semantic proximity Read ↗

Analysis of very important pharmacogene variants in the Tibetan population from China.Semantic proximity Read ↗

Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.Semantic proximity Read ↗

Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province.Semantic proximity Read ↗

Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.Semantic proximity Read ↗

Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population.Semantic proximity Read ↗

Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.Semantic proximity Read ↗

Genetic Polymorphisms Analysis of Pharmacogenomic VIP Variants in Miao Ethnic Group of Southwest China.Semantic proximity Read ↗

Mining local exome and HLA data to characterize actionable pharmacogenetic variants in Saudi ArabiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.